During recent court proceedings against Aircraft Medical, a Scottish firm that produces the McGrath laryngoscope, Lord Hodge of the Scottish Court of Session recognized the validity of the GlideScope patent.
Introduced in 2001, the GlideScope video laryngoscope provides a consistently clear view enabling quick intubation. Designed for 1st Pass Success, the brand has grown rapidly and now incorporates models for patients ranging from preterm/neonatal to bariatric, and offerings that span single use and reusable configurations.
With this victory, the company will also continue to innovate and vigorously prosecute infringements of its even broader intellectual property portfolio in the United States, Europe, and elsewhere.
About Verathon Inc.
Verathon® designs and manufactures reliable, state-of-the-art medical devices and services that offer a meaningful improvement in patient care to the health care community. The company’s noninvasive BladderScan® instrument is a standard of care for portable ultrasound bladder volume measurement. The brand is found in over 60 countries in Urology and Primary Care practices, as well as Acute and Extended Care facilities. With the acquisition of Saturn Biomedical Systems in Vancouver, Canada, Verathon entered Anesthesiology, Critical Care and Emergency markets with the GlideScope video laryngoscope brand. Verathon is headquartered in Bothell, Washington and operates as a subsidiary of Roper Industries. For more information, please visit verathon.com.
Verathon Media Contacts: Jane Mueller, VP of Marketing 425.867.1348, (Ext. 5600) and Nansea Carmichael, Executive Assistant – Marketing, 425.867.1348 (Ext. 5607).